Hillsboro Cardiology, PC

Hillsboro, Oregon 97123

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Angina Pectoris, Atrial Fibrillation, Atrial Flutter, Cardiovascular Disease, Coronary Artery Disease, Heart Failure, Congestive, Hypertension, Myocardial Infarction, Percutaneous Coronary Intervention

Studies at this site

• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina — Completed
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension — Stopped early
• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension — Completed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early
• Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. — Completed